Sanofi India is currently trading at Rs. 3700.00, up by 71.35 points or 1.97% from its previous closing of Rs. 3628.65 on the BSE.
The scrip opened at Rs. 3635.00 and has touched a high and low of Rs. 3715.00 and Rs. 3616.00 respectively. So far 772 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 3800.00 on 21-Nov-2014 and a 52 week low of Rs. 2731.00 on 11-Aug-2014.
Last one week high and low of the scrip stood at Rs. 3715.00 and Rs. 3480.05 respectively. The current market cap of the company is Rs. 8515.34 crore.
The promoters holding in the company stood at 60.40% while Institutions and Non-Institutions held 29.50% and 10.10% respectively.
Sanofi India has received an approval for selling its commercial property, being land admeasuring 5493.1 square meters bearing Survey No. 54-A Hissa No. 2 and C.T.S. No. 18 of Village Chakala, along with building known as ‘Aventis House' standing thereon, situated at Sir Mathuradas Vasanji Road, Andheri (East) Mumbai for a consideration of Rs 111.00 crore.
The built-up area of the building (comprising of basement and two upper floors) is approximately 69,600 square feet. The transaction is subject to certain conditions precedent and is expected to be completed in the quarter ending September 30, 2015.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |